Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype
Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype
复制标题
DOI:
10.1007/s10585-013-9628-z
复制
发表时间:
2014-03-01
影响因子:
4
通讯作者:
Nakamura, Seiji
中科院分区:
文献类型:
--
作者:
Goto, Yuichi;Kawano, Shintaro;Nakamura, Seiji
Epithelial-to-mesenchymal transition (EMT), an essential developmental program, is involved in tumor progression. Delta Np63, a homolog of p53, is associated with the EMT program, but the detailed mechanism remains to be elucidated. In this study, we investigated the role of Delta Np63 in EMT during progression of oral squamous cell carcinoma (OSCC). Five OSCC cell lines and specimens from 78 patients with OSCC were used. The expressions of Delta Np63, p63 alpha, p63 beta and epithelial markers (cytokeratins 5 and 14) was detected in the OSCC cells, but not in SQUU-B cells (high metastatic potential). E-cadherin was expressed in all OSCC cells. Mesenchymal markers were strongly expressed in the SQUU-B cells. Knockdown of endogenous Delta Np63 in HSC-2 cells induced morphological changes to the spindle shape, decreased the expression of epithelial markers, increased the expression of mesenchymal markers, increased migration and reduced proliferation. By contrast, SQUU-B cells overexpressing Delta Np63 beta showed changed their morphology from stromal cell-like to epithelial cells. However, E-cadherin expression was not affected by Delta Np63 knockdown or overexpression. Immunohistochemical staining revealed that cancer cells expressing vimentin were found at the invasive front in the OSCC specimens. The intensity of Delta Np63 expression was also decreased in these cells. Interestingly, the vimentin positivity or decreased intensity of Delta Np63 was positively associated with metastases and poor prognosis in the OSCC patients. These results indicated that Delta Np63 downregulation in cancer cells induces a mesenchymal phenotype that is related to tumor progression of OSCC.